RT @sentimentstock: Look at that long list of 69 distinguished neurosurgeons on this comprehensive article for the 2017 interim blinded dat…
RT @sentimentstock: Look at that long list of 69 distinguished neurosurgeons on this comprehensive article for the 2017 interim blinded dat…
RT @Sojourner618: $NWBO Pub is out! https://t.co/Ccqnu7Wxa6
RT @ChrisLacoursier: $NWBO #Biotech DATA IS BETTER Than I hoped! BREATHTAKING #ASCO18 $IBB $CNCR @bradloncar #GoBoldly https://t.co/oOZFb12…
RT @JohnWarner1970: $nwbo https://t.co/fWEaMOtdkc
RT @sentimentstock: GBM patients in $NWBO's #DCVax-L trial methylated MGMT (131) had mOS of 34.7 months past surgery with a 3-year survival…
RT @herkyleese: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed gl…
RT @justinkeister5: As Haray Caray would say....How about that!?!? #GBM $NWBO #homerunforbraincancerpatients https://t.co/VFg1Kx5YSf
Look at that long list of 69 distinguished neurosurgeons on this comprehensive article for the 2017 interim blinded data on the #DCVax-L #GBM trial for newly diagnosed #glioblastoma. They wanted to get this early peek out as they believe in its promise.
RT @sentimentstock: $NWBO First Results on survival from large P3 clinical trial of #DCVax-L in newly diagnosed glioblastoma out. #CNBC #Im…
RT @sentimentstock: $NWBO Gotta pull out that recent @PhRMA #goboldly ad for the dendritic cells "Beauty is a Beast" (that they haven't do…
RT @herkyleese: @JSTBiotech Check out https://t.co/FnnKvQbDDC. $nwbo #dcvax is going to change everything.
RT @justinkeister5: As Haray Caray would say....How about that!?!? #GBM $NWBO #homerunforbraincancerpatients https://t.co/VFg1Kx5YSf
$NWBO First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma https://t.co/PO8PPtUobH
This is pretty amazing: mOS 34.7 months from surgery, with a 3-year survival of 46.4%. #DCVax #glioblastoma First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly... https://t.co/18ngxHCJtv #
As Haray Caray would say....How about that!?!? #GBM $NWBO #homerunforbraincancerpatients https://t.co/VFg1Kx5YSf
RT @herkyleese: @JSTBiotech Check out https://t.co/FnnKvQbDDC. $nwbo #dcvax is going to change everything.
$NWBO Gotta pull out that recent @PhRMA #goboldly ad for the dendritic cells "Beauty is a Beast" (that they haven't done much with lately - what's wrong with those Big Pharma people?). https://t.co/Z914BX44Bb https://t.co/Ojc1wkaWpv
RT @sentimentstock: GBM patients in $NWBO's #DCVax-L trial methylated MGMT (131) had mOS of 34.7 months past surgery with a 3-year survival…
RT @sentimentstock: GBM patients in $NWBO's #DCVax-L trial methylated MGMT (131) had mOS of 34.7 months past surgery with a 3-year survival…
RT @sentimentstock: $NWBO First Results on survival from large P3 clinical trial of #DCVax-L in newly diagnosed glioblastoma out. #CNBC #Im…
RT @sentimentstock: GBM patients in $NWBO's #DCVax-L trial methylated MGMT (131) had mOS of 34.7 months past surgery with a 3-year survival…
RT @sentimentstock: GBM patients in $NWBO's #DCVax-L trial methylated MGMT (131) had mOS of 34.7 months past surgery with a 3-year survival…
RT @sentimentstock: GBM patients in $NWBO's #DCVax-L trial methylated MGMT (131) had mOS of 34.7 months past surgery with a 3-year survival…
RT @sentimentstock: GBM patients in $NWBO's #DCVax-L trial methylated MGMT (131) had mOS of 34.7 months past surgery with a 3-year survival…
RT @Sojourner618: $NWBO Pub is out! https://t.co/Ccqnu7Wxa6
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell #vaccine in newly diagnosed #glioblastoma encouraging https://t.co/KI5QixGEXr #
GBM patients in $NWBO's #DCVax-L trial methylated MGMT (131) had mOS of 34.7 months past surgery with a 3-year survival of 46.4% 223 patients ≥ 30 months past surgery 182 patients ≥ 36 months past surgery Note: this is 2017 data! @BrainTumourNews http
Американска фармацевтична компания докладва обещаващ резултат от нов подход за лечение на глиобластома, вид мозъчен тумор, който включва ваксиниране с естракт от тумора и собствени имунни клетки. Терапията е удължила двойно живота на някои от болните. http
@JSTBiotech Check out https://t.co/FnnKvQbDDC. $nwbo #dcvax is going to change everything.
RT @sentimentstock: $NWBO First Results on survival from large P3 clinical trial of #DCVax-L in newly diagnosed glioblastoma out. #CNBC #Im…
RT @sentimentstock: $NWBO First Results on survival from large P3 clinical trial of #DCVax-L in newly diagnosed glioblastoma out. #CNBC #Im…
RT @Sojourner618: $NWBO Pub is out! https://t.co/Ccqnu7Wxa6
$NWBO Pub is out! https://t.co/Ccqnu7Wxa6
RT @sentimentstock: $NWBO First Results on survival from large P3 clinical trial of #DCVax-L in newly diagnosed glioblastoma out. #CNBC #Im…
RT @sentimentstock: $NWBO First Results on survival from large P3 clinical trial of #DCVax-L in newly diagnosed glioblastoma out. #CNBC #Im…
$NWBO #GBM https://t.co/XYmhyZ8XDx
RT @herkyleese: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed gl…
RT @herkyleese: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed gl…
@SGottliebFDA #gbm Dr Gottlieb, We need access to this vaccine NOW. https://t.co/q9VD8Pggb1
RT @sentimentstock: $NWBO First Results on survival from large P3 clinical trial of #DCVax-L in newly diagnosed glioblastoma out. #CNBC #Im…
$NWBO https://t.co/1NRjWxhX42
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell #vaccine in newly diagnosed glioblastoma https://t.co/mbkJDDotAj #BrainTumour
$nwbo https://t.co/fWEaMOtdkc
$NWBO First Results on survival from large P3 clinical trial of #DCVax-L in newly diagnosed glioblastoma out. #CNBC #Immunotherapy #GBM #Glioblastoma #GoGreyinMay #GoGrayinMay @business @megtirrell https://t.co/Z914BX44Bb
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma | Journal of Translational Medicine | Full Text https://t.co/FnnKvQbDDC $nwbo Shared via Bing Search https://t.co/ZGR82U
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma https://t.co/q9VD8Pggb1